Related Experiment Videos
Pericarditis due to anaerobic bacteria
1Department of Pediatrics, Georgetown University School of Medicine, Washington, DC, USA. ib6@georgetown.edu
Cardiology
|April 30, 2002
Summary
Pericarditis caused by anaerobic bacteria, including Bacteroides, Clostridium, and Fusobacterium, requires specific antimicrobial susceptibility testing. Prompt diagnosis and targeted antibiotic therapy are crucial for effective management of these infections.
Area of Science:
- Infectious Diseases
- Microbiology
- Cardiology
Background:
- Pericarditis, inflammation of the pericardium, can be caused by various microorganisms.
- Anaerobic bacteria are an under-recognized cause of pericarditis, with distinct microbiological profiles.
- Understanding the sources and characteristics of anaerobic pericarditis is vital for clinical management.
Purpose of the Study:
- To review the microbiology, diagnosis, and management of pericarditis caused by anaerobic bacteria.
- To identify the predominant anaerobic organisms involved in pericarditis.
- To highlight the importance of antimicrobial susceptibility testing for anaerobic pathogens.
Main Methods:
- Literature review of studies reporting pericarditis due to anaerobic bacteria.
- Analysis of predominant anaerobic species and their sources of infection.
- Comparison of clinical diagnostic features with aerobic/facultative bacterial pericarditis.
Main Results:
- Predominant anaerobes include Bacteroides fragilis group, anaerobic streptococci, Clostridium, Fusobacterium, and Bifidobacterium.
- Infection mechanisms include contiguous spread, endocarditis, hematogenous spread, and direct inoculation.
- No significant differences in clinical diagnostic features were observed compared to aerobic pericarditis.
Conclusions:
- Anaerobic gram-negative bacilli show increasing resistance to common antibiotics.
- Complete identification and antimicrobial susceptibility testing are essential for guiding treatment.
- Effective antibiotic therapy targeting anaerobic organisms is key for managing anaerobic pericarditis.